BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9131445)

  • 1. Expansion of blood CD34+ cells: committed precursor expansion does not affect immature hematopoietic progenitors.
    David S; Boiron JM; Dupouy M; Rice A; Vianes I; Duperray V; Reiffers J
    J Hematother; 1997 Apr; 6(2):151-8. PubMed ID: 9131445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors.
    David S; Rice A; Vianes I; Duperray V; Dupouy M; Reiffers J
    Nouv Rev Fr Hematol (1978); 1995; 37(6):343-9. PubMed ID: 8907630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
    van de Ven C; Ishizawa L; Law P; Cairo MS
    Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
    Purdy MH; Hogan CJ; Hami L; McNiece I; Franklin W; Jones RB; Bearman SI; Berenson RJ; Cagnoni PJ; Heimfeld S
    J Hematother; 1995 Dec; 4(6):515-25. PubMed ID: 8846011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of CD34 + CD38- cord blood cells.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; De Hemptinne D; Stryckmans P
    J Hematother; 1997 Apr; 6(2):93-102. PubMed ID: 9131438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
    McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S
    Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-mediated expansion does not deplete cord blood cells with stem cell characteristics.
    Rice AM; Case J; Vowels MR
    Hematol Cell Ther; 1997 Jun; 39(3):125-31. PubMed ID: 9262988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity.
    Wyrsch A; dalle Carbonare V; Jansen W; Chklovskaia E; Nissen C; Surbek D; Holzgreve W; Tichelli A; Wodnar-Filipowicz A
    Exp Hematol; 1999 Aug; 27(8):1338-45. PubMed ID: 10428511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is in vitro expansion of human cord blood cells clinically relevant?
    Denning-Kendall PA; Nicol A; Horsley H; Donaldson C; Bradley B; Hows JM
    Bone Marrow Transplant; 1998 Feb; 21(3):225-32. PubMed ID: 9489644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.
    Lill MC; Lynch M; Fraser JK; Chung GY; Schiller G; Glaspy JA; Souza L; Baldwin GC; Gasson JC
    Stem Cells; 1994 Nov; 12(6):626-37. PubMed ID: 7533581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.